Oruka Therapeutics, Inc. · Brief

Next report

5 days

Nov 5 · after closeest.Q3 FY26

Earnings

Expected move

Inputs

±9.3%implied · straddle

87.88105.86

spot 96.87exp Nov 20ATM strike 95ATM straddle 10.58IV 54%

Oct 30 close

Expected move

Inputs

Implied vs realized

8 reportsHistory

—≥ implied

Jul 21 '23—▼−0.49%—

Oct 18 '23—▼−0.49%—

Feb 1 '24—▲+2.55%—

Apr 25 '24—▲+2.87%—

Aug 1 '24—▲+5.07%—

Sep 5 '24—▲+2.80%—

Q1 FY26±11.0%▼−8.52%×0.78

Q2 FY26±14.7%▲+6.40%×0.44

quarterimplied−15%0+15%realized×

Q2 FY26±14.7%▲+6.40%×0.44

Q1 FY26±11.0%▼−8.52%×0.78

Sep '24—▲+2.80%—

Aug '24—▲+5.07%—

Apr '24—▲+2.87%—

Feb '24—▲+2.55%—

2 older reports

Oct '23—▼−0.49%—

Jul '23—▼−0.49%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull1

+22.59%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 4

4tracked funds holding ORKAN-PORT · Aug 31 '26

1.38%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

ORKA report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 22impliedImplied move: ±12.9% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.